Neuronetics, Inc. (STIM): Cost of Revenue
$76.85M
Year ended 2025-12-31
$78.91M
Trailing 12 months to 2026-06-30
+70.6%
3-year compound annual growth
+46.1%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $76.85M | +270.7% | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | $20.73M | +5.5% | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | $19.64M | +26.9% | 2026-03-17, From 2023-01-01 |
| 2022-12-31 | $15.48M | +32.9% | 2025-03-27, From 2022-01-01 |
| 2021-12-31 | $11.65M | +0.9% | 2024-03-08, From 2021-01-01 |
| 2020-12-31 | $11.55M | -24.9% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $15.39M | +23.6% | 2022-03-08, From 2019-01-01 |
| 2018-12-31 | $12.45M | +29.2% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $9.63M | +45.5% | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $6.62M | n/a | 2019-03-05, From 2016-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | 2025-12-31 | $76.85M | +270.7% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $63.14M | -2.0% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $49.65M | +1.2% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $40.84M | +30.2% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $66.82M | -37.2% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $49.01M | +11.6% |
| SI-BONE, Inc. (SIBN) | 2025-12-31 | $41.05M | +17.1% |
| Treace Medical Concepts, Inc. (TMCI) | 2025-12-31 | $42.94M | +4.5% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $44.71M | +52.9% |
Compare STIM, INFU, XTNT, HTFL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗